BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27292259)

  • 1. PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells.
    Banasavadi-Siddegowda YK; Russell L; Frair E; Karkhanis VA; Relation T; Yoo JY; Zhang J; Sif S; Imitola J; Baiocchi R; Kaur B
    Oncogene; 2017 Jan; 36(2):263-274. PubMed ID: 27292259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRMT5 as a druggable target for glioblastoma therapy.
    Banasavadi-Siddegowda YK; Welker AM; An M; Yang X; Zhou W; Shi G; Imitola J; Li C; Hsu S; Wang J; Phelps M; Zhang J; Beattie CE; Baiocchi R; Kaur B
    Neuro Oncol; 2018 May; 20(6):753-763. PubMed ID: 29106602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastoma.
    Otani Y; Sur HP; Rachaiah G; Namagiri S; Chowdhury A; Lewis CT; Shimizu T; Gangaplara A; Wang X; Vézina A; Maric D; Jackson S; Yan Y; Zhengping Z; Ray-Chaudhury A; Kumar S; Ballester LY; Chittiboina P; Yoo JY; Heiss J; Kaur B; Banasavadi-Siddegowda YK
    Neuro Oncol; 2021 Sep; 23(9):1481-1493. PubMed ID: 33556161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting protein arginine methyltransferase 5 sensitizes glioblastoma to trametinib.
    Banasavadi-Siddegowda YK; Namagiri S; Otani Y; Sur H; Rivas S; Bryant JP; Shellbourn A; Rock M; Chowdhury A; Lewis CT; Shimizu T; Walbridge S; Kumarasamy S; Shah AH; Lee TJ; Maric D; Yan Y; Yoo JY; Kumbar SG; Heiss JD; Kaur B
    Neurooncol Adv; 2022; 4(1):vdac095. PubMed ID: 35875691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protein arginine methyltransferase PRMT5 confers therapeutic resistance to mTOR inhibition in glioblastoma.
    Holmes B; Benavides-Serrato A; Saunders JT; Landon KA; Schreck AJ; Nishimura RN; Gera J
    J Neurooncol; 2019 Oct; 145(1):11-22. PubMed ID: 31473880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma.
    Yan F; Alinari L; Lustberg ME; Martin LK; Cordero-Nieves HM; Banasavadi-Siddegowda Y; Virk S; Barnholtz-Sloan J; Bell EH; Wojton J; Jacob NK; Chakravarti A; Nowicki MO; Wu X; Lapalombella R; Datta J; Yu B; Gordon K; Haseley A; Patton JT; Smith PL; Ryu J; Zhang X; Mo X; Marcucci G; Nuovo G; Kwon CH; Byrd JC; Chiocca EA; Li C; Sif S; Jacob S; Lawler S; Kaur B; Baiocchi RA
    Cancer Res; 2014 Mar; 74(6):1752-65. PubMed ID: 24453002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRMT5 inhibition disrupts splicing and stemness in glioblastoma.
    Sachamitr P; Ho JC; Ciamponi FE; Ba-Alawi W; Coutinho FJ; Guilhamon P; Kushida MM; Cavalli FMG; Lee L; Rastegar N; Vu V; Sánchez-Osuna M; Coulombe-Huntington J; Kanshin E; Whetstone H; Durand M; Thibault P; Hart K; Mangos M; Veyhl J; Chen W; Tran N; Duong BC; Aman AM; Che X; Lan X; Whitley O; Zaslaver O; Barsyte-Lovejoy D; Richards LM; Restall I; Caudy A; Röst HL; Bonday ZQ; Bernstein M; Das S; Cusimano MD; Spears J; Bader GD; Pugh TJ; Tyers M; Lupien M; Haibe-Kains B; Artee Luchman H; Weiss S; Massirer KB; Prinos P; Arrowsmith CH; Dirks PB
    Nat Commun; 2021 Feb; 12(1):979. PubMed ID: 33579912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature.
    Jones KA; Gilder AS; Lam MS; Du N; Banki MA; Merati A; Pizzo DP; VandenBerg SR; Gonias SL
    Neuro Oncol; 2016 May; 18(5):667-78. PubMed ID: 26420897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting PRMT5/Akt signalling axis prevents human lung cancer cell growth.
    Zhang S; Ma Y; Hu X; Zheng Y; Chen X
    J Cell Mol Med; 2019 Feb; 23(2):1333-1342. PubMed ID: 30461193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FKBP38 Regulates Self-Renewal and Survival of GBM Neurospheres.
    Dowling AL; Walbridge S; Ertekin C; Namagiri S; Camacho K; Chowdhury A; Bryant JP; Kohut E; Heiss JD; Brown DA; Kumbar SG; Banasavadi-Siddegowda YK
    Cells; 2023 Nov; 12(21):. PubMed ID: 37947640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo.
    Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A
    Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; dePinho RA
    Cold Spring Harb Symp Quant Biol; 2008; 73():427-37. PubMed ID: 19150964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.
    Ghosh D; Ulasov IV; Chen L; Harkins LE; Wallenborg K; Hothi P; Rostad S; Hood L; Cobbs CS
    Stem Cells; 2016 Sep; 34(9):2276-89. PubMed ID: 27354342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K/Akt and Stat3 signaling regulated by PTEN control of the cancer stem cell population, proliferation and senescence in a glioblastoma cell line.
    Moon SH; Kim DK; Cha Y; Jeon I; Song J; Park KS
    Int J Oncol; 2013 Mar; 42(3):921-8. PubMed ID: 23314408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
    Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
    Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells.
    Lamballe F; Toscano S; Conti F; Arechederra M; Baeza N; Figarella-Branger D; Helmbacher F; Maina F
    Oncotarget; 2016 Nov; 7(46):74747-74767. PubMed ID: 27732969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hedgehog signaling regulates brain tumor-initiating cell proliferation and portends shorter survival for patients with PTEN-coexpressing glioblastomas.
    Xu Q; Yuan X; Liu G; Black KL; Yu JS
    Stem Cells; 2008 Dec; 26(12):3018-26. PubMed ID: 18787206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cox-2-derived PGE2 induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma.
    Cook PJ; Thomas R; Kingsley PJ; Shimizu F; Montrose DC; Marnett LJ; Tabar VS; Dannenberg AJ; Benezra R
    Neuro Oncol; 2016 Oct; 18(10):1379-89. PubMed ID: 27022132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.